Beone Medicines Ltd. Class A · SSE:688235

Oyler John sold 60,218 Beone Medicines Ltd. Class A shares (Form 4)

Traded Jul 10 to Jul 13, 2026 · Filed Jul 14, 2026

From Jul 10 to Jul 13, 2026, Oyler John (Director, Chief Executive Officer) sold 60,218 Beone Medicines Ltd. Class A shares at an average US$303.18 for US$18.3M under a trading plan, leaving 0 shares. Filed Jul 14, 2026 (Form 4).

Sold
60,218 shares
Price
US$303.18 average (US$296.07 to US$307.41)
Value
US$18.3M
Holding after
0 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 10, 2026American Depositary SharesOption exercise11,698US$36.9011,698Direct
Jul 10, 2026American Depositary SharesSale1,493US$296.0710,205Direct
Jul 10, 2026American Depositary SharesSale1,314US$297.238,891Direct
Jul 10, 2026American Depositary SharesSale3,074US$298.355,817Direct
Jul 10, 2026American Depositary SharesSale5,143US$298.94674Direct
Jul 10, 2026American Depositary SharesSale370US$300.12304Direct
Jul 10, 2026American Depositary SharesSale150US$301.18154Direct
Jul 10, 2026American Depositary SharesSale136US$302.1918Direct
Jul 10, 2026American Depositary SharesSale18US$303.030Direct
Jul 13, 2026American Depositary SharesOption exercise48,520US$36.9048,520Direct
Jul 13, 2026American Depositary SharesSale798US$301.9447,722Direct
Jul 13, 2026American Depositary SharesSale4,584US$302.7943,138Direct
Jul 13, 2026American Depositary SharesSale26,294US$303.8316,844Direct
Jul 13, 2026American Depositary SharesSale8,438US$304.688,406Direct
Jul 13, 2026American Depositary SharesSale846US$305.577,560Direct
Jul 13, 2026American Depositary SharesSale7,240US$306.82320Direct
Jul 13, 2026American Depositary SharesSale320US$307.410Direct

Source

View original at SEC

Related